WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2017177013) ALK7 ANTAGONISTS AND USES THEREOF
Latest bibliographic data on file with the International Bureau    Submit observation

Pub. No.:    WO/2017/177013    International Application No.:    PCT/US2017/026372
Publication Date: 12.10.2017 International Filing Date: 06.04.2017
IPC:
A61P 3/00 (2006.01), A61P 3/04 (2006.01), A61P 3/06 (2006.01), A61P 3/10 (2006.01), A61P 13/12 (2006.01), A61P 1/16 (2006.01), A61P 35/00 (2006.01), A61K 38/16 (2006.01)
Applicants: ACCELERON PHARMA INC. [US/US]; 128 Sidney Street Cambridge, MA 02139 (US)
Inventors: KNOPF, John; (US).
KUMAR, Ravindra; (US).
GRINBERG, Asya; (US).
PEARSALL, Robert, Scott; (US).
SAKO, Dianne, S.; (US).
CASTONGUAY, Roselyne; (US).
LI, Gang; (US).
DAGON, Yossi; (US)
Agent: VARMA, Anita; (US)
Priority Data:
62/341,391 25.05.2016 US
62/319,219 06.04.2016 US
Title (EN) ALK7 ANTAGONISTS AND USES THEREOF
(FR) ANTAGONISTES D’ALK7 ET LEURS UTILISATIONS
Abstract: front page image
(EN)In certain aspects, the disclosure provides ALK7 antagonists. In certain aspects, these ALK7 antagonists are can be used to improve metabolic parameters in a patient in need thereof. In certain aspects, these ALK7 antagonists can be used to treat or prevent one or more kidney-associated disease or condition in a patient in need thereof. In certain aspects, these ALK7 antagonists can be used to treat or prevent cancer.
(FR)Dans certains aspects, l'invention concerne des antagonistes d'ALK7. Selon certains aspects, ces antagonistes d’ALK7 sont/peuvent être utilisés pour améliorer des paramètres métaboliques chez un patient qui en a besoin. Selon certains aspects, ces antagonistes d’ALK7 peuvent être utilisés pour traiter ou prévenir une ou plusieurs maladies ou affections associées au rein chez un patient qui en a besoin. Dans certains aspects, ces antagonistes d'ALK7 peuvent être utilisés pour traiter ou prévenir le cancer.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)